![Alexion lab with a hand holding a syringe needle](/-/media/alexion_comredesign/images/non-patient-images/lab-07-s.jpg?rev=c6a6ec8664ed49bf90d49b9fe4ce3e11?mw=375 375w,
/-/media/alexion_comredesign/images/non-patient-images/lab-07-s.jpg?rev=c6a6ec8664ed49bf90d49b9fe4ce3e11?mw=750 750w,
/-/media/alexion_comredesign/images/non-patient-images/lab-07-s.jpg?rev=c6a6ec8664ed49bf90d49b9fe4ce3e11?mw=768 768w,
/-/media/alexion_comredesign/images/non-patient-images/lab-07-s.jpg?rev=c6a6ec8664ed49bf90d49b9fe4ce3e11?mw=1024 1024w,
/-/media/alexion_comredesign/images/non-patient-images/lab-07-s.jpg?rev=c6a6ec8664ed49bf90d49b9fe4ce3e11?mw=1280 1280w,
/-/media/alexion_comredesign/images/non-patient-images/lab-07-s.jpg?rev=c6a6ec8664ed49bf90d49b9fe4ce3e11?mw=1536 1536w,
/-/media/alexion_comredesign/images/non-patient-images/lab-07-s.jpg?rev=c6a6ec8664ed49bf90d49b9fe4ce3e11?mw=2048 2048w,
/-/media/alexion_comredesign/images/non-patient-images/lab-07-s.jpg?rev=c6a6ec8664ed49bf90d49b9fe4ce3e11?mw=2560 2560w )
MEDICINES
We Are Changing Lives Every Day
To date, we have six innovative medicines approved for the treatment of seven rare diseases and devastating conditions. Learn more about each of our medicines and the conditions they treat by selecting a product below.
![Kanuma Logo](/-/media/Alexion_comRedesign/Images/Medicines/2-2-kanuma-logo.jpg)
KANUMA®
![Koselugo logo](/-/media/Alexion_comRedesign/Images/Medicines/2-2-Koselugo-logo.jpg)
KOSELUGO®
![Soliris Logo](/-/media/Alexion_comRedesign/Images/Medicines/2-2-soliris-logo.jpg)
SOLIRIS®
![Strensiq Logo](/-/media/Alexion_comRedesign/Images/Medicines/2-2-strensiq-logo.jpg)
STRENSIQ®
![Ultomiris Logo](/-/media/Alexion_comRedesign/Images/Medicines/2-2-ultomiris-logo.jpg)
ULTOMIRIS®
![Voydeya Logo](/-/media/Alexion_comRedesign/Images/Medicines/2-2-Voydeya-logo.jpg)
VOYDEYATM
Contact Alexion in your region if you are outside of the United States and want to learn about product availability.
Related Topics
Learn more about the diseases we’re fighting
CONDITIONS WE TREAT
See how we’re pushing the boundaries of rare disease research every day
PIPELINE
US/ALL/0209